Inorganic Pyrophosphate in Peripheral Arterial Disease

Inorganic Pyrophosphate in Peripheral Arterial Disease - iPPAD study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON48386

Enrollment

Registered

2019-05-24

Start date

2019-01-28

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intermitent claudication Peripheral arterial disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Age 18 and older. 2. One of four grades of Fontaine classification: a. Fontaine I: Asymptomatic, incomplete blood vessel obstruction. b. Fontaine II: Mild claudication pain in limb. c. Fontaine III: Rest pain, mostly in the feet. d. Fontaine IV: Necrosis and/or gangrene of the limb.

Exclusion criteria

Exclusion criteria: 1. Subjects who are unable or unwilling to sign an informed consent.

Design outcomes

Primary

Measure	Time frame
Differences in plasma PPi levels in patients with PAD with different Fontaine stages and healthy controls.	—

Secondary

Measure	Time frame
Differences in other plasma calcification inhibitors in patients with PAD with different Fontaine stages and healthy controls.	—

Countries

Netherlands

Outcome results